Systemic sclerosis and inflammatory myopathy after treatment with durvalumab in a patient with rectal neoplasm

MeSH terms

• Antibodies, Monoclonal* / adverse effects
• Antineoplastic Agents, Immunological / adverse effects
• Female
• Humans
• Male
• Middle Aged
• Myositis* / chemically induced
• Myositis* / diagnosis
• Rectal Neoplasms* / drug therapy
• Rectal Neoplasms* / pathology
• Scleroderma, Systemic* / chemically induced
• Scleroderma, Systemic* / complications
• Scleroderma, Systemic* / drug therapy
• Treatment Outcome